My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Letybo



Croma-Pharma GmbHPA0846/001/001

Main Information

Trade NameLetybo
Active SubstancesClostridium Botulinum Neurotoxin Type A (900 KD)
Dosage FormPowder for solution for injection
Licence HolderCroma-Pharma GmbH
Licence NumberPA0846/001/001

Group Information

ATC CodeM03AX01 botulinum toxin

Status

License statusAuthorised
Licence Issued25/03/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print